Key result
De novo ACTA1 Met327Lys mutation linked to CFTD and DCM induces muscle cell apoptosis.
Why the study?
Only eight patients with congenital fiber-type disproportion, including one with dilated cardiomyopathy, had been previously reported in association with ACTA1 mutations.
Case Report (n=1)
A novel de novo ACTA1 mutation (Met327Lys) was identified in a pediatric patient with CFTD and DCM, with in vitro studies suggesting apoptosis as a potential pathogenic mechanism.
Suggests ACTA1 screening in pediatric CFTD-DCM; leaves open broader prevalence and management implications.
BACKGROUND: Actin, alpha, skeletal muscle 1 (ACTA1) is one of the causative genes of nemaline myopathy (NM) and congenital fiber-type disproportion (CFTD). CFTD is characterized by type 1 fiber atrophy and distinguished from NM in the absence of rods. Eight patients with CFTD, including one patient with dilated cardiomyopathy (DCM), have previously been reported. Herein, we report the case of a 10-year-old boy presenting with CFTD and DCM. METHODS: We performed exome sequencing and analyzed the effect of Met327Lys mutations on cultured C2C12 muscle cells compared with that seen in the wild type (WT, ACTA1) and previously identified Asp294Val mutations associated with a severe phenotype of CFTD without cardiomyopathy. RESULTS: Exome sequencing revealed a de novo mutation, c.980 T > A, p.(Met327Lys), in ACTA1 (NM_001100.4). C2C12 cells transfected with the WT plasmid expressed ACTA1 in the nucleus and cytoplasm. Cells with the Asp294Val mutant showed needle-like structures in the cytoplasm, whereas the expression of the Met327Lys mutant resulted in few aggregations but many apoptotic cells. CONCLUSION: Apoptosis induced in Met327Lys-transfected muscle cells supports the pathogenicity of the mutation and can be implicated as one of the histopathological features associated with CFTD, as in NM.
No takes yet. Share an insight, caveat, or question.
Matsumoto et al. (2022) conducted a case report in Congenital fiber-type disproportion syndrome (CFTD) and dilated cardiomyopathy (DCM) (n=1). ACTA1 Met327Lys mutation vs. Wild type (WT, ACTA1) and Asp294Val mutations was evaluated on Pathogenicity of the mutation (apoptosis in transfected muscle cells). A de novo ACTA1 Met327Lys mutation was identified in a 10-year-old boy with CFTD and DCM, which induced apoptosis in transfected muscle cells, supporting its pathogenicity.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: